On March 29, the House Science Committee convened a hearing titled, “Climate Science: Assumptions, Policy Implications, and the Scientific Method.” The scientific method has become a central issue in the committee’s work this year. The House has passed two bills to overhaul how the Environmental Protection Agency uses and reviews science. Proponents say the legislation would … Continue reading Climate Science: Assumptions, Policy Implications, and the Scientific Method
S. 442: National Aeronautics and Space Administration Transition Authorization Act of 2017 The federal budget process occurs in two stages: appropriations and authorizations. This is an authorization bill, which direct how federal funds should or should not be used. Appropriations set overall spending limits by agency or program and are typically made for single fiscal years … Continue reading NASA Transition Authorization Act Allocates $19.508 Billion for 2017
President Trump signed two STEM related bills into law (February 28, 2017): HR 321 and HR 255. HR 321: Inspiring the Next Space Pioneers, Innovators, Researchers, and Explorers (INSPIRE) Women Act” directs NASA “to encourage women and girls to study science, technology, engineering, and mathematics (STEM), pursue careers in aerospace, and further advance the nation’s space … Continue reading STEM Education Bills Signed by President Trump
This bill authorizes FY2017 appropriations and sets forth policies regarding the military activities of the Department of Defense (DOD), military construction, and the national security programs of the Department of Energy (DOE).
Federal science agencies in general will be barred from starting new programs or stopping old ones and from implementing funding increases submitted in the president’s fiscal year 2017 budget request.
S. 612 Water Infrastructure Improvement for the Nation (WiiN) Act, S.612, with a vote of 78-21 drew a mix of Republications and Democrats on each side. A bill must be passed by both the House and Senate in identical form and then signed by the President to become law.
21st Century Cures Act PASSES Senate 94-5 . More than $192 million in lobbying expenses have been spent on the 21st Century Cures Act and other legislative priorities by 58 pharmaceutical companies, 24 device companies and 26 biotech companies, according to a Kaiser Health News analysis of lobbying data compiled by the Center for Responsive Politics.